Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Peptide Therapy SummitPeptide Therapy Summit
Not Confirmed
Not Confirmed
03-05 April, 2025
Not Confirmed
Not Confirmed
05-09 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Peptide Therapy SummitPeptide Therapy Summit
Industry Trade Show
Not Confirmed
03-05 April, 2025
Industry Trade Show
Not Confirmed
05-09 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
27 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cstone-pharmaceuticals-announces-2024-annual-results-and-recent-business-progress-302413130.html
25 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cstone-to-showcase-five-latest-research-achievements-at-aacr-2025-302407851.html
23 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cstone-submits-application-to-the-european-medicines-agency-for-new-indication-of-sugemalimab-in-stage-iii-non-small-cell-lung-cancer-302408587.html
05 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cstone-submits-clinical-trial-application-in-australia-for-cs5001-ror1-adc-in-combination-with-first-line-standard-of-care-for-dlbcl-302393846.html
03 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cstone-announces-first-patient-dosed-in-global-multicenter-phase-i-clinical-trial-of-cs2009-a-pd-1vegfctla-4-trispecific-antibody-302389842.html
24 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cstone-announces-publication-of-gemstone-303-study-results-for-sugemalimab-cejemly-in-jama-302384091.html
ABOUT THIS PAGE